Related references
Note: Only part of the references are listed.Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity
Shih-Lung Woo et al.
PLOS ONE (2014)
AICAR inhibits PPAR during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids
Dmitry Namgaladze et al.
CARDIOVASCULAR RESEARCH (2013)
A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats
Christopher R. Lindholm et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2013)
β-Carotene Attenuates Angiotensin II-Induced Aortic Aneurysm by Alleviating Macrophage Recruitment in Apoe-/- Mice
Kaliappan Gopal et al.
PLOS ONE (2013)
Activation of Sterol Regulatory Element Binding Protein and NLRP3 Inflammasome in Atherosclerotic Lesion Development in Diabetic Pigs
Yu Li et al.
PLOS ONE (2013)
RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity
Weifang Yu et al.
ATHEROSCLEROSIS (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Dyslipidemia Associated with Poor Glycemic Control in Type 2 Diabetes Mellitus and the Protective Effect of Metformin Supplementation
Yonas Mullugeta et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2012)
Macrophages in the Pathogenesis of Atherosclerosis
Kathryn J. Moore et al.
CELL (2011)
IL-1R-Associated Kinase-1 Mediates Protein Kinase Cδ-Induced IL-1β Production in Monocytes
Rajiv Lochan Tiwari et al.
JOURNAL OF IMMUNOLOGY (2011)
AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3)
A. Nerstedt et al.
DIABETOLOGIA (2010)
Macrophage α1 AMP-activated Protein Kinase (α1AMPK) Antagonizes Fatty Acid-induced Inflammation through SIRT1
Zhenggang Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
AMPK in Health and Disease
Gregory R. Steinberg et al.
PHYSIOLOGICAL REVIEWS (2009)
Adenosine 5′-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype
Duygu Sag et al.
JOURNAL OF IMMUNOLOGY (2008)
被撤回的出版物: Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase (Retracted article. See vol. 294, pg. 10741, 2019)
Yong Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The immune response in atherosclerosis: a double-edged sword
Goran K. Hansson et al.
NATURE REVIEWS IMMUNOLOGY (2006)
α-Lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase
WJ Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice
D Gavrila et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus
F Abbasi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells
MW Zang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes
K Matsumoto et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2004)
The macrophage foam cell as a target for therapeutic intervention
AC Li et al.
NATURE MEDICINE (2002)
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes
N Musi et al.
DIABETES (2002)
Biomechanical strain induces class a scavenger receptor expression in human monocyte/macrophages and THP-1 cells - A potential mechanism of increased atherosclerosis in hypertension
H Sakamoto et al.
CIRCULATION (2001)
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice
A Daugherty et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)